|
Policosanol in patients with metabolic syndrome and ischaemic cardiopaty |
|
Policosanol in Coronary Artery Disease |
|
Policosanol for long term-Ictus |
|
Policosanol + aspirin in post-stroke cognitive impairment |
|
Podal Reflex Laserpuncture as a treatment for Chronic Adenoiditis - Phase III |
|
Pneumococcal conjugate vaccination among Warao children |
|
PLASMA TREATMENT TO ASYMPTOMATIC PATIENT WITH COVID-19 INFECTION |
|
Phyisician Led CIMAvax-EGF lung biomarkers |
|
Phenamate in the treatment of prostate cancer |
|
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana |
|
Phase III clinical trial: Dermofural®. Mild infection in diabetic foot ulcer |
|
Phase II-III study to evaluate the safety and immunogenicity of the pneumococcal vaccine candidate VCN11 in adult participants aged 50 to 74 years. |
|
Phase II-III clinical trial to evaluate the vaccine candidate against pneumococcal diseases VCN11 in infants |
|
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . |
|
Phase II clinical trial for the evaluation of the therapeutic vaccine candidate Terap C. |
|
Phase II / III. Nimotuzumab in patients with triple-negative breast cancer. |
|
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique. |
|
Phase I/II trial with the mutein no alfa of IL-2 |
|
Phase I/II clinical trial for the evaluation of vaccine candidate CIGB-230 in patients with chronic renal insufficiency. |
|
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba. |
